Literature DB >> 24177003

Measuring central pulmonary pressures during exercise in COPD: how to cope with respiratory effects.

Bart G Boerrigter1, Aaron B Waxman, Nico Westerhof, Anton Vonk-Noordegraaf, David M Systrom.   

Abstract

Respiratory influences are major confounders when evaluating central haemodynamics during exercise. We studied four different methods to assess mean pulmonary artery pressure (mPAP) and pulmonary capillary wedge pressure (PCWP) in cases of respiratory swings. Central haemodynamics were measured simultaneously with oesophageal pressure during exercise in 30 chronic obstructive pulmonary disease (COPD) patients. mPAP and PCWP were assessed at the end of expiration, averaged over the respiratory cycle and corrected for the right atrial pressure (RAP) waveform estimated intrathoracic pressure, and compared with the transmural pressures. Bland-Altman analyses showed the best agreement of mPAP averaged over the respiratory cycle (bias (limits of agreement) 2.5 (-6.0-11.8) mmHg) and when corrected with the nadir of RAP (-3.6 (-11.2-3.9) mmHg). Measuring mPAP at the end of expiration (10.3 (0.5-20.3) mmHg) and mPAP corrected for the RAP swing (-9.3 (-19.8-2.1) mmHg) resulted in lower levels of agreement. The respiratory swings in mPAP and PCWP were similar (r(2)=0.82, slope ± se 0.95 ± 0.1). Central haemodynamics measured at the end of expiration leads to an overestimation of intravascular pressures in exercising COPD patients. Good measurement can be acquired even when oesopghageal pressure is omitted, by averaging pressures over the respiratory cycle or using the RAP waveform to correct for intrathoracic pressure. Assessment of the pulmonary gradient is unaffected by respiratory swings.

Entities:  

Mesh:

Year:  2013        PMID: 24177003     DOI: 10.1183/09031936.00016913

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  22 in total

Review 1.  Protocol for exercise hemodynamic assessment: performing an invasive cardiopulmonary exercise test in clinical practice.

Authors:  Natalia C Berry; Agarwal Manyoo; William M Oldham; Thomas E Stephens; Ronald H Goldstein; Aaron B Waxman; Julie A Tracy; Peter J Leary; Jane A Leopold; Scott Kinlay; Alexander R Opotowsky; David M Systrom; Bradley A Maron
Journal:  Pulm Circ       Date:  2015-12       Impact factor: 3.017

2.  Unexplained exertional intolerance associated with impaired systemic oxygen extraction.

Authors:  Kathryn H Melamed; Mário Santos; Rudolf K F Oliveira; Mariana Faria Urbina; Donna Felsenstein; Alexander R Opotowsky; Aaron B Waxman; David M Systrom
Journal:  Eur J Appl Physiol       Date:  2019-09-06       Impact factor: 3.078

3.  Reliance on end-expiratory wedge pressure leads to misclassification of pulmonary hypertension.

Authors:  Barbara L LeVarge; Eugene Pomerantsev; Richard N Channick
Journal:  Eur Respir J       Date:  2014-06-12       Impact factor: 16.671

Review 4.  The Evolving Landscape of Exercise-Induced Pulmonary Hypertension.

Authors:  J Sawalla Guseh
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-06

5.  Potential Role of Cardiopulmonary Exercise Testing as an Early Screening Tool for Patients With Suspected Pulmonary Hypertension Including Exercise-Induced Pulmonary Hypertension: Results From a Retrospective Analysis.

Authors:  Zulfiqar Qutrio Baloch; Shabber Agha Abbas; Rohan Madhu Prasad; Amin M Elamin; Abbas Ali
Journal:  Perm J       Date:  2021-06-09

6.  Pulmonary Vascular and Right Ventricular Burden During Exercise in Interstitial Lung Disease.

Authors:  Rudolf K F Oliveira; Aaron B Waxman; Paul J Hoover; Paul F Dellaripa; David M Systrom
Journal:  Chest       Date:  2020-03-12       Impact factor: 9.410

Review 7.  Pulmonary Vascular Disease: Hemodynamic Assessment and Treatment Selection-Focus on Group II Pulmonary Hypertension.

Authors:  Bhavadharini Ramu; Brian A Houston; Ryan J Tedford
Journal:  Curr Heart Fail Rep       Date:  2018-04

8.  Patent foramen ovale is not associated with hypoxemia in severe chronic obstructive pulmonary disease and does not impair exercise performance.

Authors:  Zarrin F Shaikh; Julia L Kelly; Dinesh Shrikrishna; Manuel de Villa; Michael J Mullen; Nicholas S Hopkinson; Mary J Morrell; Michael I Polkey
Journal:  Am J Respir Crit Care Med       Date:  2014-03-01       Impact factor: 21.405

9.  Hemodynamic evidence of vascular remodeling in combined post- and precapillary pulmonary hypertension.

Authors:  Tufik R Assad; Evan L Brittain; Quinn S Wells; Eric H Farber-Eger; Stephen J Halliday; Laura N Doss; Meng Xu; Li Wang; Frank E Harrell; Chang Yu; Ivan M Robbins; John H Newman; Anna R Hemnes
Journal:  Pulm Circ       Date:  2016-09       Impact factor: 3.017

10.  Comprehensive Diagnostic Evaluation of Cardiovascular Physiology in Patients With Pulmonary Vascular Disease: Insights From the PVDOMICS Program.

Authors:  W H Wilson Tang; Jennifer D Wilcox; Miriam S Jacob; Erika B Rosenzweig; Barry A Borlaug; Robert P Frantz; Paul M Hassoun; Anna R Hemnes; Nicholas S Hill; Evelyn M Horn; Harsimran S Singh; David M Systrom; Ryan J Tedford; Rebecca R Vanderpool; Aaron B Waxman; Lei Xiao; Jane A Leopold; Franz P Rischard
Journal:  Circ Heart Fail       Date:  2020-02-24       Impact factor: 8.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.